82613-08-9

Basic information

• Product Name: Benzoyl chloride, 3-ethoxy-4-methoxy- (9CI)
• Synonyms: Benzoyl chloride, 3-ethoxy-4-methoxy- (9CI);3-ETHOXY-4-METHOXY-BENZOYL CHLORIDE
• CAS NO: 82613-08-9
• Molecular Formula: C₁₀H₁₁ClO₃
• Molecular Weight: 214.64554
• Product Categories: ACIDHALIDE
• Mol File: 82613-08-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoyl chloride, 3-ethoxy-4-methoxy- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoyl chloride, 3-ethoxy-4-methoxy- (9CI)(82613-08-9)
• EPA Substance Registry System: Benzoyl chloride, 3-ethoxy-4-methoxy- (9CI)(82613-08-9)

Safety Data

• Hazardous Substances Data: 82613-08-9(Hazardous Substances Data)

Upstream product

• 17892-42-1 O,O-diethylmelannein 
• 2651-55-0 3-ethoxy-4-methoxybenzoic acid 

Downstream Products

• 1349175-47-8 N-(3,5-dichloropyridin-4-yl)-3-ethoxy-4-methoxybenzamide 
• 82613-11-4 6-Hydroxy-7-methoxy-4-(3'-ethoxy-4'-methoxyphenyl)coumarin 
• 82613-10-3 Ethyl m-ethoxy-p-methoxybenzoylacetate 
• 31526-71-3 3-ethoxy-4-methoxy-acetophenone 
• 17892-42-1 O,O-diethylmelannein 
• 1092789-44-0 2-((3-ethoxy-4-methoxyphenyl)carbonyl)malononitrile 
• 17892-45-4 3'.5-Diethoxy-2.4.4'-trimethoxy-benzophenon 
• 17892-44-3 2-Hydroxy-3'.5-diethoxy-4.4'-dimethoxy-benzophenon 
• 17892-47-6 3'.4-Diethoxy-2.5.4'-trimethoxy-benzophenon 
• 18008-38-3 2-Hydroxy-3'.4-diethoxy-4'.5-dimethoxy-benzophenon 
• 203395-36-2 3-ethoxy-4,3',4'-trimethoxy-benzophenone 

Relevant articles and documents

Ambroxol derivative, and preparation method, medicinal composition and application thereof

The invention relates to the field of medicinal chemistry, and concretely relates to an ambroxol derivative or pharmaceutically acceptable salts thereof, and a preparation method, a medicinal composition and a medical application thereof. The ambroxol derivative is a compound with a structure represented by formula I shown in the specification, and R in the formula I is defined in claims.

Kinase antagonists

The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tryosine kinase, PI3Kinase and mTOR, or PI3Kinase, mTOR and tryosine kinase.